Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer’s disease
Acta Neuropathologica · 2024
DOI: 10.1007/s00401-024-02814-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Ye-Ran Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Amyloid Precursor Protein Secretases, Alzheimer Disease, Aspartic Acid Endopeptidases, Autoantibodies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovative Research Group Project of the National Natural Science Foundation of China, National-Level Reserve Talent Program of the Chongqing Health Commission.
Themen: Demenz
Abstract (Originalsprache)
The profile of autoantibodies is dysregulated in patients with Alzheimer's disease (AD). Autoantibodies to beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1) are present in human blood. This study aims to investigate the clinical relevance and pathophysiological roles of autoantibodies to BACE1 in AD. Clinical investigations were conducted in two independent cohorts, the Chongqing cohort, and the Australian Imaging, Biomarkers, and Lifestyle (AIBL) cohort. The Chongqing cohort included 55 AD patients, 28 patients with non-AD dementia, and 70 cognitively normal subjects (CN). The AIBL cohort included 162 Aβ-PET- CN, 169 Aβ-PET+ cognitively normal subjects (preclinical AD), and 31 Aβ-PET+ cognitively impaired subjects (Clinical AD). Plasma autoantibodies to BACE1 were determined by one-site Elisa. The associations of plasma autoantibodies to BACE1 with brain Aβ load and cognitive trajectory were investigated. The effects of autoantibodies to BACE1 on AD-type pathologies and underlying mechanisms were investigated in APP/PS1 mice and SH/APPswe/PS1wt cell lines. In the Chongqing cohort, plasma autoantibodies to BACE1 were higher in AD patients, in comparison with CN and non-AD dementia patients. In the AIBL cohort, plasma autoantibodies to BACE1 were highest in clinical AD patients, followed by preclinical AD and CN subjects. Higher autoantibodies to BACE1 were associated with an increased incidence of brain amyloid positivity conversion during follow-up. Autoantibodies to BACE1 exacerbated brain amyloid deposition and subsequent AD-type pathologies, including Tau hyperphosphorylation, neuroinflammation, and neurodegeneration in APP/PS1 mice. Autoantibodies to BACE1 increased Aβ production by promoting BACE1 expression through inhibiting PPARγ signaling. These findings suggest that autoantibodies to BACE1 are pathogenic in AD and the upregulation of these autoantibodies may promote the development of the disease. This study offers new insights into the mechanism of AD from an autoimmune perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.
- Key Laboratory of Aging and Brain Disease, Chongqing, China.
- Centre of Health Management, Daping Hospital, Third Military Medical University, Chongqing, China.
- The Florey Institute, The University of Melbourne, Parkville, VIC, Australia.
- The Australian E-Health Research Centre, CSIRO, Herston, QLD, Australia.
- CogState, Melbourne, VIC, Australia.
ORCID-Profile: Yan-Jiang Wang
Förderung
- National Natural Science Foundation of China
- Innovative Research Group Project of the National Natural Science Foundation of China
- National-Level Reserve Talent Program of the Chongqing Health Commission
Zitieren
APA
Wang, Y. R., Zeng, X. Q., Wang, J., Fowler, C. J., Li, Q. X., Bu, X. L., Doecke, J., Maruff, P., Martins, R. N., Rowe, C. C., Masters, C. L., Wang, Y. J., & Liu, Y. H. (2024). Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer’s disease. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02814-x
Vancouver
Wang YR, Zeng XQ, Wang J, Fowler CJ, Li QX, Bu XL, et al. Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer’s disease. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02814-x
BibTeX
@article{Wang2024,
author = {Wang, Ye-Ran and Zeng, Xiao-Qin and Wang, Jun and Fowler, Christopher J and Li, Qiao-Xin and Bu, Xian-Le and Doecke, James and Maruff, Paul and Martins, Ralph N and Rowe, Christopher C and Masters, Colin L and Wang, Yan-Jiang and Liu, Yu-Hui},
title = {Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer’s disease},
journal = {Acta Neuropathologica},
year = {2024},
doi = {10.1007/s00401-024-02814-x}
}
EUVIMED